SNOW · Snowflake Inc.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.280 to $272.030, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $277.000 to $277.990, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $278.000 to $278.700, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.730 to $275.720, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.200 to $270.110, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.380 to $273.300, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The stock option is fully vested.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.420 to $274.410, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.230 to $271.060, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.920 to $273.915, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.900 to $271.890, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $267.380 to $267.980, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.920 to $274.915, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $276.940 to $277.250, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.830 to $270.825, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.920 to $275.915, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $275.930 to $276.870, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.900 to $272.890, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $268.805 to $269.780, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.

The stock option is fully vested.

The sale and gift reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026.

The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee.

The sale and gift reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026.

The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee.

Each performance stock unit ("PSU") represents a contingent right to receive one share of Issuer's common stock.

The PSUs are divided into five tranches, each with an applicable performance period, the vesting of which is based on the achievement of both a service-based requirement and a stock price requirement. The service-based requirement will be met on September 15, 2029 for tranches 1 and 2, containing an aggregate of 250,000 PSUs, and September 15, 2030 for tranches 3, 4 and 5, containing an aggregate of 750,000 PSUs, in each case, subject to the Reporting Person's service as Issuer's Chief Executive Officer through each such date. The stock price requirement with respect to each tranche will be met on the date on which the compensation committee of Issuer's board of directors certifies that, prior to the end of the applicable performance period, the average closing price per share of Issuer's common stock over a consecutive ninety (90) calendar day period has met or exceeded the applicable stock price target previously determined by the compensation committee.

The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $257.940 to $258.800, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $257.120 to $257.750, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.860 to $253.880, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.860 to $253.880, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $259.565 to $260.100, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $259.565 to $260.100, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $255.010 to $255.970, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $259.565 to $260.100, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $257.940 to $258.800, inclusive.

Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $260.300 to $261.140, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $263.465 to $264.430, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $255.010 to $255.970, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $254.000 to $254.950, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $262.310 to $263.290, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $261.330 to $262.290, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $255.010 to $255.970, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $254.000 to $254.950, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $257.120 to $257.750, inclusive.

Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $263.465 to $264.430, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $261.330 to $262.290, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.860 to $253.880, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $259.565 to $260.100, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.860 to $253.880, inclusive.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024.

The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $262.310 to $263.290, inclusive.

Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.